CSIMarket


Medpace Holdings Inc   (MEDP)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


 

Medpace Holdings Inc

MEDP's Financial Statements and Analysis



Medpace Holdings Inc reported in the forth quarter of 2023 net earnings per share of $2.50 an increase by 13.12 % year on year from $2.21 and an improvement of 12.39 % from $2.22 realized in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 2.5 $  498 Mill
$+0.29     +13.12 % $+104M     +26.47 %



Medpace Holdings Inc 's Revenue rose by 26.47 % in forth quarter of 2023 (Dec 31 2023) year on year, to $498 million and advanced by 1.2 % sequentially.


Medpace Holdings Inc is

More on MEDP's Income Statement



Medpace Holdings Inc 's net income of $78.298 million in the forth quarter of 2023 increased by 14.02 % from net earnings of $68.670 million achieved in IV. Quarter a year ago.

Sequentially net earnings grew by 10.98 % from net income of $70.550 million realized in previous quarter.

More on MEDP's Growth

Medpace Holdings Inc Inventories
MEDP's Cash flow In the forth quarter of 2023 company's net cash flow was $150 million, capital expenditures fell by -9.2438.04%, to $-10 millions compare to same quarter a year ago

More on MEDP's Cash flow Statement


Medpace Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Medpace Holdings Inc earned $ 13.61 cash per share, on a free-cash flow basis 152.55 % of net earning per share.

Book value grew by 18.37 % sequentially to $17.55 per share, 68.27% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -4.37 per share from $ -7.17.

Company issued 0.09 million shares or 0.27 % in Dec 31 2023.
Interest Coverage Ratio was 81.38. Debt Coverage Ratio was 8.

More on MEDP's Dividends

 Market Capitalization (Millions) 12,827
 Shares Outstanding (Millions) 32
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,886
 Net Income (TTM) (Millions $) 283
 Cash Flow (TTM) (Millions $) 217
 Capital Exp. (TTM) (Millions $) -37
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 3,900




Medpace Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Medpace Holdings Inc had $ 13.61 cash flow per share, on a free-cash flow basis 152.55 % of net earning per share.

Book value grew by 18.37 % sequentially to $17.55 per share, 68.27% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -4.37 per share from $ -7.17.

Company issued 0.09 million shares or 0.27 % in Dec 31 2023.
Interest Coverage Ratio was 81.38. Debt Coverage Ratio was 8.

More on MEDP's Balance Sheets

 Market Capitalization (Millions) 12,827
 Shares Outstanding (Millions) 32
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,886
 Net Income (TTM) (Millions $) 283
 Cash Flow (TTM) (Millions $) 217
 Capital Exp. (TTM) (Millions $) -37
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 3,900
   


  News about Medpace Holdings Inc Earnings

Medpace Holdings Inc Reports Impressive 13.12% Growth in Income for October to December 31, 2023 Financial Period

The stock market is often unpredictable, with ups and downs that can leave investors feeling uncertain. However, there are moments when a company's performance stands out, shining a light on the potential for fruitful investments. Medpace Holdings Inc, a Medical Laboratories company, is one such example, as their recent financial results have surpassed expectations.
In the October to December 31, 2023 financial time-frame, Medpace Holdings Inc's earnings per share (EPS) grew by an impressive 13.12% to $2.50 per share, compared to $2.21 from the previous year. Not only that, but the EPS also grew by 12.39% from $2.22 per share in the preceding quarter. These numbers indicate a consistent upward trend, dem...

Medpace Holdings Inc. Records Impressive 8.29% Surge in Bottom-line Profits, Smashing Expectations for Q3 2023 Earnings Season

Bearish Outlook for Medpace Holdings Inc. in the Third Quarter of 2023 Earnings Season
Despite the positive earnings report for the third quarter of 2023, Medpace Holdings Inc may face challenges and decreasing profitability in the near future. While the company experienced a surge in income per share and revenue growth, there are several warning signs that investors should consider.
Firstly, while the income per share increased by 8.29% compared to last year, it is important to note that this growth rate is lower than in previous reporting seasons. In addition, the EPS surged by 15.03% from the previous reporting season, which is not a sustainable trend and may indicate a potential slowdown in futur...

Medpace Holdings Inc Announces Skyrocketing Earnings in Q2 2023, with Revenue and Profits Surging by Over 30%

Medpace Holdings Inc Delivers Astonishing Q2 Earnings, Poses Promising Future for Investors
In a surprising turn of events, medical laboratories company, Medpace Holdings Inc, has reported astonishing earnings in the second quarter of 2023. The company's revenue saw an impressive increase of 31.224% to reach $460.87 million, while profit per share rose by 32.19% to $1.93 per share, year on year. These figures outperformed the revenue of $434.07 million and $2.27 per share reported in the preceding reporting season.
Furthermore, the bottom-line of $61.068 million for the financial period ending on June 30, 2023, experienced a remarkable growth of 23.72% from the net earnings of $49.360 million recorde...


Date modified: 2024-02-16T21:44:26+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com